Invention Grant
- Patent Title: Heterocyclic compounds as immunomodulators
-
Application No.: US17119488Application Date: 2020-12-11
-
Publication No.: US11407749B2Publication Date: 2022-08-09
- Inventor: Liangxing Wu , Bo Shen , Jingwei Li , Zhenwu Li , Kai Liu , Fenglei Zhang , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04
Abstract:
Disclosed are compounds of Formula (I′), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Public/Granted literature
- US20210347771A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS Public/Granted day:2021-11-11
Information query
